Publication | Closed Access

Addition of cetuximab to oxaliplatin-based first-line combination chemotherapy for treatment of advanced colorectal cancer: results of the randomised phase 3 MRC COIN trial

Gastrointestinal OncologyMedicineRandomised Phase 3PathologyColorectal CancerCancer TreatmentAdvanced Colorectal CancerOncologyRadiation OncologyCancer ResearchMrc Coin Trial